CHELMSFORD, Mass.--(BUSINESS WIRE)--Sept. 7, 2006--ZOLL Medical Corporation (NASDAQ: ZOLL), a manufacturer of resuscitation devices and related software solutions, today reported that A. Ernest Whiton, its Chief Financial Officer and Vice President of Administration, is entering into a 10b5-1 sales plan for the sale of up to 19,250 shares of ZOLL common stock over an approximate 12-month period. It is expected that approximately 5,000 shares will be sold each quarter, depending on market conditions, commencing in the first quarter of fiscal 2007, by Mr. Whiton pursuant to the plan. The shares to be sold will be acquired upon the exercise of stock options which were granted to Mr. Whiton at the time he joined the Company and have been outstanding for more than seven years.
